TrialNature medicine2025

Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial.

Sherene Loi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.